Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeMedical MasksLABMED Ships 65 Mil + Medical Masks 38 Mil Virus Transport Medium...

LABMED Ships 65 Mil + Medical Masks 38 Mil Virus Transport Medium Kits Internationally

LBMED, a Singapore based company, reported today that they have shipped over 65 million masks worldwide. The company specializes in the manufacture of disposable civil mask, medical mask, surgical mask, KN95-FFP2 mask and other medical instruments.

LABMED is currently supplying these much-needed masks and medical devices to Singapore, the US State of Hawaii, the UK, Italy, Germany, India and South Africa.

LABMED has also shipped 38 million VTM (Virus Transport Medium) kits worldwide. These VTMs are a crucial part of the battle against Covid-19, as they are coupled with the nasal swab kits, and they hold the completed swabs that will be sent to laboratories for testing.

The demand for VTM nasal swabs kits and saliva collection kit is expected to rise with the current situation with most countries going through community testing, while the global face mask market is expected to register phenomenal growth by the end of 2020,” says LABMED’s Regional Managing Director, Wilson.

The prominence that LABMED plays in the fight against the Covid-19 pandemic has also guided how it gives back to the communities that are affected by this international crisis.

“As governments, NGOs and healthcare agencies respond to this pandemic, we thought about how to give back to our community.  Fortunately, we are in a good position to offer assistance, and we actively donate and contribute to the less fortunate so they are also taken care of during tough times like these when their financials are impacted,” shares Regional Managing Director, Wilson.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy